A phase II trial of imatinib mesylate in merkel cell carcinoma (Neuroendocrine carcinoma of the skin): A Southwest oncology group study (S0331)

Wolfram E. Samlowski, James Moon, Ralph J. Tuthill, Michael C. Heinrich, Naomi S. Balzer-Haas, Stuart A. Merl, Ronald C. DeConti, John A. Thompson, Merle T. Witter, Lawrence E. Flaherty, Vernon K. Sondak

Research output: Contribution to journalArticlepeer-review

67 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II trial of imatinib mesylate in merkel cell carcinoma (Neuroendocrine carcinoma of the skin): A Southwest oncology group study (S0331)'. Together they form a unique fingerprint.

Medicine & Life Sciences